Back to the main directory
EarningsReview / Equity
- FII (601138 CH) by HSBC
- 杰瑞股份（002353 CH） by HSBC
- Telstra Group (TLS AU) by HSBC
- 韦尔股份（603501 CH） by HSBC
- Troax Group - Proficient operations safeguard potential by Danske Bank Equity Research
- Galaxy Entertainment (27 HK) by HSBC
- Zealand Pharma - Confirms start of Phase 3 in Obesity by Danske Bank Equity Research
- Publishing MandG IFRS 17 model by BNP Paribas Exane
- Q223 Postview (+ 15 questions for management) by BNP Paribas Exane
- Itaú BBA on Despegar: Best 2Q EBITDA in Company History by Itau
- Itaú BBA on Arcos Dorados: Slight Adjusted EBITDA Beat in 2Q23 by Itau
- Awaiting visibility into margin expansion by BNP Paribas Exane
- GN Store Nord - Estimates reset – Enterprise stabilisation TBC by Danske Bank Equity Research
- FQ4 results: first take by BNP Paribas Exane
- Surgical Science (Buy, TP: SEK282.00) - Set for another strong quarter by DnB Markets
- Elmera Group (Sell, TP: NOK15.00) - by DnB Markets
- Coloplast (Buy, TP: DKK940.00) - Low end of margin guidance likely by DnB Markets
- Elopak (Hold, TP: NOK24.00) - Q2 confirms cost control by DnB Markets
- Nibe Industrier (Hold, TP: SEK85.00) - Heat pump order intake uncertainty by DnB Markets
- Axactor (Buy, TP: NOK6.80) - Addressing key funding risks by DnB Markets
- Kojamo (Hold, TP: EUR9.00) - Hunkering down by DnB Markets
- 2020 Bulkers Minor model adjustments by DnB Markets
- GN Group (Buy, TP: DKK215.00) - Hearing beat, but Audio miss by DnB Markets
- Itaú BBA on Adecoagro: Another Set of Strong S&E Results Drives Slight Beat by Itau
- Itaú BBA on Cencosud: Nice EBITDA Beat in 2Q23, but In-Line EPS by Itau